Patent ID: 8067606
Filing Date: 2011-11-29
Classification: A61K,A61P,C07D

Abstract:
1. A method of controlling, treating or reducing the advancement, severity or effects of a nosocomial or a non-nosocomial bacterial infection in a patient, wherein the bacterial infection is characterized by the presence of one or more of the following: Methicillin resistant Staphylococci, Fluoroquinolone resistant Staphylococci, Glycopepetide resistant Staphylococci, Macrolide-Lincosamide-Streptogramin resistant Staphylococci, Linezolid resistant Enterococci, Glycopepetide resistant Enterococci, β-lactam resistant Enterococci, Penicillin resistant or a pharmaceutically acceptable salt thereof, wherein: W is selected from nitrogen, CH, or CF; X is selected from CH or CF; Z is O or NH; R y is 0 or 1; T is a straight or branched C each R′ is independently selected from hydrogen, C Ar is a 3-8 membered saturated, unsaturated, or aryl ring, a 3-7 membered heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered heteroaryl ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, wherein: R Ring A is a pyridine wherein: